U.S. Court of Appeals for the Federal Circuit, 2017

Takeda Pharmaceutical Company v. Sun Pharma Global Fze

Takeda Pharmaceutical Company v. Sun Pharma Global Fze
U.S. Court of Appeals for the Federal Circuit · Decided April 10, 2017

Takeda Pharmaceutical Company v. Sun Pharma Global Fze

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., TAKEDA PHARMACEUTICALS AMERICA, INC., Plaintiffs-Appellants v. SUN PHARMA GLOBAL FZE, SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellees ______________________ 2016-2325 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 3:14-cv-04616-MLC-TJB, Judge Mary L. Cooper. ______________________ JUDGMENT ______________________ ARLENE L. CHOW, Hogan Lovells US LLP, New York, NY, argued for plaintiffs-appellants. Also represented by ERIC J. LOBENFELD, THOMAS SCHMIDT.

MARK DAVID SCHUMAN, Carlson, Caspers, Vanden- burgh, Lindquist & Schuman, P.A., Minneapolis, MN, argued for defendants-appellees. Also represented by SAMUEL T. LOCKNER, JONATHAN CARPENTER, CAROLINE MARSILI. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (PROST, Chief Judge, NEWMAN and DYK, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

April 10, 2017 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.